Aurora Cannabis Inc. (NYSE:ACB) in recent session today was buoying at with a rise of 4.08% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $13.72 and 5Y monthly beta was reading 1.55 with its price kept floating in the range of $13.83 and $15.24 on the day. Company’s P/E ratio for the trailing 12 months is 66.11. Considering stock’s 52-week price range provides that ACB hit a high price of $95.76 and saw its price falling to a low level of $5.3 during that period. Over a period of past 1-month, stock came losing -21.15% in its value.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with nil upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review ACB stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 50% Sell for it.

In comparing Aurora Cannabis Inc. (ACB)’s stock with other industry players reveals that stock’s latest price change of +4.08% and that of -84.34% over the past 12 months is in competing position with that of Abbott Laboratories (ABT) which saw its stock price raised by 1.61% in the recent trading and went through an increase of 6.28% in past 12-month trading. Industry’s another major player Medtronic Inc (MDT) has jumped 0.73% up in latest trading session, but over the past year has faced a fall of -6.09%, while Stryker Corp (SYK) is also up 4.08% however its price remained floating in the red at -84.34% over the same period. Aurora Cannabis Inc. has a P/E ratio of 63.52 against that of Abbott Laboratories’s 45.33 while Medtronic Inc is showing 26.5 for the same. On the other hand, the S&P 500 Index was up 0.68% in the early deals while the Dow Jones Industrial was dealing higher at 0.8%.

Having a second look at Aurora Cannabis Inc. (NYSE:ACB) provides that stock’s average daily trading volume for 3 months was 10.45 Million, while it jumped to 4.54 Million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock currently stood at 112.57 Million.

Data compiled by Thomson Reuters highlights that percentage of outstanding shares held by the insiders is 2.9% while it is 12.27% for the institutional holders. The figures also indicate that as of May 28, 2020, number of stock’s short shares was 21290000 which implies a short ratio of 1.03. This shows up a 19.42% of Short Interest in company’s outstanding shares on the day. In May the standing of shares short improved as it was 18.58 Million in the previous month. Drop of -47.07% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ worries about the stock as it is hinting a further drop.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.